Prognostic influence of 5 alpha reductase inhibitors in patients with localized prostate cancer under active surveillance

Ozkan T. A., Cebeci O. O., Cevik I., DİLLİOĞLUGİL Ö.

TURKISH JOURNAL OF UROLOGY, vol.44, no.2, pp.132-137, 2018 (ESCI, Scopus, TRDizin) identifier identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 2
  • Publication Date: 2018
  • Doi Number: 10.5152/tud.2017.39660
  • Journal Name: TURKISH JOURNAL OF UROLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.132-137
  • Keywords: 5-alpha-reductase inhibitors, active surveillance, prostate cancer, DUTASTERIDE, PROGRESSION, GUIDELINES, DIAGNOSIS, BIOPSY, RISK, MEN
  • Kocaeli University Affiliated: Yes

Abstract

Objective: The incidence of prostate adenocarcinoma (PCa) is increased with the use of prostate-specific antigen (PSA). In the current study, we aimed to investigate the impact of 5-alpha-reductase inhibitors (5-ARI) on pathological progression in patients followed by active surveillance (AS).